Combination Treatment of TRPV4 Agonist with Cisplatin Promotes Vessel Normalization in an Animal Model of Oral Squamous Cell Carcinoma

Background and Objectives: Oral squamous cell carcinoma (OSCC) is the sixth most common malignancy in the world. Transient receptor potential vanilloid 4 (TRPV4) channel has been shown to be involved in angiogenesis in multiple types of tumors. However, not much is known about TRPV4′s involvement in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yahya, Farhana, Mohd Bakri, Marina, Hossain, Mohammad Zakir, Syed Abdul Rahman, Syarifah Nur, Mohammed Alabsi, Aied, Ramanathan, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504292/
https://www.ncbi.nlm.nih.gov/pubmed/36143906
http://dx.doi.org/10.3390/medicina58091229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504292/
https://www.ncbi.nlm.nih.gov/pubmed/36143906
http://dx.doi.org/10.3390/medicina58091229

Ejemplares similares